Select country change
Shopping cart (0 , 0,00 ) Menu Search

Scientific References

BioVendor collects scientific publications where the use of our immunoassays, recombinant proteins, and monoclonal and polyclonal antibodies is cited.

Filter references:
  • References to Adipocyte FABP (FABP4) Human ELISA

    • Aeberli I, Beljean N, Lehmann R, I'Allemand D, Spinas GA, Zimmermann MB. Theincrease of fatty acid-binding protein aP2 in overweight and obese children:interactions with dietary fat and impact on measures of subclinical inflammation.Int J Obes (Lond). 2008 Oct;32(10):1513-20. doi: 10.1038/ijo.2008.128. Epub 2008 Aug 5. PubMed PMID: 18679408. See more on PubMed
    • Andrés Cerezo L, Kuklová M, Hulejová H, Vernerová Z, Pešáková V, Pecha O,Veigl D, Haluzík M, Pavelka K, Vencovský J, Senolt L. The level of fattyacid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritisand correlates with serum cholesterol levels. Cytokine. 2013 Oct;64(1):441-7.doi: 10.1016/j.cyto.2013.05.001. Epub 2013 May 25. PubMed PMID: 23714112. See more on PubMed
    • Aragonès G, Ferré R, Lázaro I, Cabré A, Plana N, Merino J, Heras M, Girona J, Masana L. Fatty acid-binding protein 4 is associated with endothelial dysfunctionin patients with type 2 diabetes. Atherosclerosis. 2010 Nov;213(1):329-31. doi:10.1016/j.atherosclerosis.2010.07.026. Epub 2010 Jul 27. PubMed PMID: 20723896. See more on PubMed
    • Aragonès G, Saavedra P, Heras M, Cabré A, Girona J, Masana L. Fattyacid-binding protein 4 impairs the insulin-dependent nitric oxide pathway invascular endothelial cells. Cardiovasc Diabetol. 2012 Jun 18;11:72. doi:10.1186/1475-2840-11-72. PubMed PMID: 22709426; PubMed Central PMCID: PMC3503556. See more on PubMed
    • Baessler A, Lamounier-Zepter V, Fenk S, Strack C, Lahmann C, Loew T, SchmitzG, Blüher M, Bornstein SR, Fischer M. Adipocyte fatty acid-binding protein levelsare associated with left ventricular diastolic dysfunction in morbidly obesesubjects. Nutr Diabetes. 2014 Feb 10;4:e106. doi: 10.1038/nutd.2014.3. PubMedPMID: 24513579; PubMed Central PMCID: PMC3940827. See more on PubMed
    • Bagheri R, Qasim AN, Mehta NN, Terembula K, Kapoor S, Braunstein S, Schutta M,Iqbal N, Lehrke M, Reilly MP. Relation of plasma fatty acid binding proteins 4and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus. Am J Cardiol. 2010 Oct 15;106(8):1118-23. doi:10.1016/j.amjcard.2010.06.028. PubMed PMID: 20920650; PubMed Central PMCID:PMC3108486. See more on PubMed
    • Bao Y, Lu Z, Zhou M, Li H, Wang Y, Gao M, Wei M, Jia W. Serum levels ofadipocyte fatty acid-binding protein are associated with the severity of coronaryartery disease in Chinese women. PLoS One. 2011 Apr 28;6(4):e19115. doi:10.1371/journal.pone.0019115. PubMed PMID: 21552513; PubMed Central PMCID:PMC3084261. See more on PubMed
    • Ben Yahia R, Lichnovská R, Janusová L, Kuzmina G, Karpísek M, Kollár P, PetrekJ. [Healthy persons versus patients with diabetes mellitus type 2--choosenparameters in serum and subcutaneous abdominal adipose tissue]. Vnitr Lek. 2007Jan;53(1):9, 11-7. Czech. PubMed PMID: 17472010. See more on PubMed
    • Bol VV, Delattre AI, Reusens B, Raes M, Remacle C. Forced catch-up growthafter fetal protein restriction alters the adipose tissue gene expression programleading to obesity in adult mice. Am J Physiol Regul Integr Comp Physiol. 2009Aug;297(2):R291-9. doi: 10.1152/ajpregu.90497.2008. Epub 2009 May 20. PubMedPMID: 19458276. See more on PubMed
    • Breitling LP, Salzmann K, Rothenbacher D, Burwinkel B, Brenner H. Smoking,F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J.2012 Nov;33(22):2841-8. doi: 10.1093/eurheartj/ehs091. Epub 2012 Apr 17. PubMedPMID: 22511653. See more on PubMed
    • Bronsky J, Karpísek M, Bronská E, Pechová M, Jancíková B, Kotolová H, StejskalD, Prusa R, Nevoral J. Adiponectin, adipocyte fatty acid binding protein, andepidermal fatty acid binding protein: proteins newly identified in human breastmilk. Clin Chem. 2006 Sep;52(9):1763-70. Epub 2006 Jul 27. PubMed PMID: 16873294. See more on PubMed
    • Burak MF, Inouye KE, White A, Lee A, Tuncman G, Calay ES, Sekiya M, Tirosh A, Eguchi K, Birrane G, Lightwood D, Howells L, Odede G, Hailu H, West S, Garlish R,Neale H, Doyle C, Moore A, Hotamisligil GS. Development of a therapeuticmonoclonal antibody that targets secreted fatty acid-binding protein aP2 to treattype 2 diabetes. Sci Transl Med. 2015 Dec 23;7(319):319ra205. doi:10.1126/scitranslmed.aac6336. Epub 2015 Dec 23. PubMed PMID: 26702093. See more on PubMed
    • Cabré A, Babio N, Lázaro I, Bulló M, Garcia-Arellano A, Masana L,Salas-Salvadó J. FABP4 predicts atherogenic dyslipidemia development. ThePREDIMED study. Atherosclerosis. 2012 May;222(1):229-34. doi:10.1016/j.atherosclerosis.2012.02.003. Epub 2012 Feb 24. PubMed PMID: 22420890. See more on PubMed
    • Cabré A, Lázaro I, Cofán M, Jarauta E, Plana N, Garcia-Otín AL, Ascaso JF,Ferré R, Civeira F, Ros E, Masana L. FABP4 plasma levels are increased infamilial combined hyperlipidemia. J Lipid Res. 2010 May;51(5):1173-8. doi:10.1194/jlr.M900066. PubMed PMID: 20388924; PubMed Central PMCID: PMC2853443. See more on PubMed
    • Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Guardiola M,Heras M, Masana L. The APOA5-1131 T>C variant enhances the association betweenRBP4 and hypertriglyceridemia in diabetes. Nutr Metab Cardiovasc Dis. 2010May;20(4):243-8. doi: 10.1016/j.numecd.2009.04.003. Epub 2009 Sep 17. PubMedPMID: 19765959. See more on PubMed
    • Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Heras M,Masana L. Fatty acid binding protein 4 is increased in metabolic syndrome andwith thiazolidinedione treatment in diabetic patients. Atherosclerosis. 2007Nov;195(1):e150-8. Epub 2007 Jun 5. PubMed PMID: 17553506. See more on PubMed
    • Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Heras M,Masana L. Plasma fatty acid binding protein 4 is associated with atherogenicdyslipidemia in diabetes. J Lipid Res. 2008 Aug;49(8):1746-51. doi:10.1194/jlr.M800102-JLR200. Epub 2008 Apr 17. PubMed PMID: 18421072. See more on PubMed
    • Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Heras M,Masana L. Plasma fatty acid-binding protein 4 increases with renal dysfunction intype 2 diabetic patients without microalbuminuria. Clin Chem. 2008Jan;54(1):181-7. Epub 2007 Nov 16. PubMed PMID: 18024526. See more on PubMed
    • Castro A, Lázaro I, Selva DM, Céspedes E, Girona J, NúriaPlana, Guardiola M,Cabré A, Simó R, Masana L. APOH is increased in the plasma and liver of type 2diabetic patients with metabolic syndrome. Atherosclerosis. 2010Mar;209(1):201-5. doi: 10.1016/j.atherosclerosis.2009.09.072. Epub 2009 Oct 6.PubMed PMID: 19878946. See more on PubMed
    • Chen MC, Hsu BG, Lee CJ, Yang CF, Wang JH. High serum adipocyte fatty acidbinding protein level as a potential biomarker of aortic arterial stiffness inhypertensive patients with metabolic syndrome. Clin Chim Acta. 2017Oct;473:166-172. doi: 10.1016/j.cca.2017.08.030. Epub 2017 Aug 30. PubMed PMID:28860092. See more on PubMed
    • Choi KM, Kim TN, Yoo HJ, Lee KW, Cho GJ, Hwang TG, Baik SH, Choi DS, Kim SM.Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obesewomen. Clin Endocrinol (Oxf). 2009 Apr;70(4):569-74. doi:10.1111/j.1365-2265.2008.03374.x. Epub 2008 Aug 15. PubMed PMID: 18710473. See more on PubMed
    • Ciardi C, Tatarczyk T, Tschoner A, Kranebitter M, Niederwanger A, Ebenbichler CF, Patsch JR, Pedrini MT. Effect of postprandial lipemia on plasmaconcentrations of A-FABP, RBP-4 and visfatin. Nutr Metab Cardiovasc Dis. 2010Nov;20(9):662-8. doi: 10.1016/j.numecd.2009.05.013. Epub 2009 Aug 21. PubMedPMID: 19699625. See more on PubMed
    • Coll B, Cabre A, Alonso-Villaverde C, Lazaro I, Aragonés G, Parra S, Girona J,Masana L. The fatty acid binding protein-4 (FABP4) is a strong biomarker ofmetabolic syndrome and lipodystrophy in HIV-infected patients. Atherosclerosis.2008 Jul;199(1):147-53. Epub 2007 Nov 5. PubMed PMID: 17983623. See more on PubMed
    • Corripio R, Gónzalez-Clemente JM, Pérez-Sánchez J, Näf S, Gallart L, Nosàs R, Vendrell J, Caixàs A. Weight loss in prepubertal obese children is associatedwith a decrease in adipocyte fatty-acid-binding protein without changes inlipocalin-2: a 2-year longitudinal study. Eur J Endocrinol. 2010Dec;163(6):887-93. doi: 10.1530/EJE-10-0408. Epub 2010 Sep 24. PubMed PMID:20870707. See more on PubMed
    • Creagan ET, Chang M, Long HJ, Rubin J. Phase II clinical trial of thecombination VP-16, bleomycin, and cis-diamminedichloroplatinum in patients withadvanced upper aerodigestive squamous cell carcinoma. Head Neck Surg. 1987Mar-Apr;9(4):223-6. PubMed PMID: 2444566. See more on PubMed
    • Danziger J, Biggs ML, Niemi M, Ix JH, Kizer JR, Djoussé L, de Boer IH,Siscovick DS, Kestenbaum B, Mukamal KJ. Circulating 25-hydroxyvitamin D isassociated with insulin resistance cross-sectionally but not longitudinally inolder adults: The Cardiovascular Health Study. Metabolism. 2013Dec;62(12):1788-94. doi: 10.1016/j.metabol.2013.07.008. Epub 2013 Aug 27. PubMed PMID: 23987236; PubMed Central PMCID: PMC4159161. See more on PubMed
    • Djoussé L, Maziarz M, Biggs ML, Ix JH, Zieman SJ, Kizer JR, Lemaitre RN,Mozaffarian D, Tracy RP, Mukamal KJ, Siscovick DS, Sotoodehnia N. Plasma FattyAcid binding protein 4 and risk of sudden cardiac death in older adults. Cardiol Res Pract. 2013;2013:181054. doi: 10.1155/2013/181054. Epub 2013 Dec 28. PubMedPMID: 24455402; PubMed Central PMCID: PMC3888692. See more on PubMed
    • Durovcová V, Marek J, Hána V, Matoulek M, Zikán V, Haluzíková D, Kaválková P, Lacinová Z, Kršek M, Haluzík M. Plasma concentrations of adipocyte fatty acidbinding protein in patients with Cushing's syndrome. Physiol Res.2010;59(6):963-71. Epub 2010 Jun 9. PubMed PMID: 20533865. See more on PubMed
    • Engl J, Ciardi C, Tatarczyk T, Kaser S, Laimer M, Laimer E, Weiss H, Aigner F,Molnar C, Tilg H, Patsch JR, Ebenbichler CF. A-FABP--a biomarker associated with the metabolic syndrome and/or an indicator of weight change? Obesity (SilverSpring). 2008 Aug;16(8):1838-42. doi: 10.1038/oby.2008.273. Epub 2008 May 29.PubMed PMID: 18535557. See more on PubMed
    • Engl J, Tschoner A, Willis M, Schuster I, Kaser S, Laimer M, Biebl W, PatschJR, Mangweth B, Ebenbichler CF. Adipocyte fatty acid binding protein duringrefeeding of female patients with anorexia nervosa. Eur J Nutr. 2009Oct;48(7):403-8. doi: 10.1007/s00394-009-0027-9. Epub 2009 May 7. PubMed PMID:19421706. See more on PubMed
    • Fain JN, Tagele BM, Cheema P, Madan AK, Tichansky DS. Release of 12 adipokinesby adipose tissue, nonfat cells, and fat cells from obese women. Obesity (Silver Spring). 2010 May;18(5):890-6. doi: 10.1038/oby.2009.335. Epub 2009 Oct 15.PubMed PMID: 19834460. See more on PubMed
    • Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Kratzsch J, Lössner U,Blüher M, Stumvoll M, Faber R, Stepan H. Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am J Hypertens. 2008May;21(5):582-6. doi: 10.1038/ajh.2008.23. Epub 2008 Mar 13. PubMed PMID:18437151. See more on PubMed
    • Furuhashi M, Ishimura S, Ota H, Hayashi M, Nishitani T, Tanaka M, Yoshida H,Shimamoto K, Hotamisligil GS, Miura T. Serum fatty acid-binding protein 4 is apredictor of cardiovascular events in end-stage renal disease. PLoS One.2011;6(11):e27356. doi: 10.1371/journal.pone.0027356. Epub 2011 Nov 10. PubMedPMID: 22102888; PubMed Central PMCID: PMC3213139. See more on PubMed
    • Fuseya T, Furuhashi M, Yuda S, Muranaka A, Kawamukai M, Mita T, Ishimura S,Watanabe Y, Hoshina K, Tanaka M, Ohno K, Akasaka H, Ohnishi H, Yoshida H, Saitoh S, Shimamoto K, Miura T. Elevation of circulating fatty acid-binding protein 4 isindependently associated with left ventricular diastolic dysfunction in a generalpopulation. Cardiovasc Diabetol. 2014 Aug 21;13:126. doi:10.1186/s12933-014-0126-7. PubMed PMID: 25142635; PubMed Central PMCID:PMC4148010. See more on PubMed
    • Haider DG, Schindler K, Bohdjalian A, Prager G, Luger A, Wolzt M, Ludvik B.Plasma adipocyte and epidermal fatty acid binding protein is reduced after weightloss in obesity. Diabetes Obes Metab. 2007 Sep;9(5):761-3. Epub 2007 Mar 13.PubMed PMID: 17359244. See more on PubMed
    • Haluzík MM, Anderlová K, Dolezalová R, Adamíková A, Haluzíková D, Housová J,Svacina S, Haluzík M. Serum adipocyte fatty acid binding protein levels inpatients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment. Physiol Res. 2009;58(1):93-9. Epub 2008 Jan 17. PubMed PMID: 18198986. See more on PubMed
    • Haluzíková D, Dostálová I, Kaválková P, Roubícek T, Mráz M, Papezová H,Haluzík M. Serum concentrations of adipocyte fatty acid binding protein inpatients with anorexia nervosa. Physiol Res. 2009;58(4):577-81. Epub 2008 Jul 25.PubMed PMID: 18657008. See more on PubMed
    • Hancke K, Grubeck D, Hauser N, Kreienberg R, Weiss JM. Adipocyte fattyacid-binding protein as a novel prognostic factor in obese breast cancerpatients. Breast Cancer Res Treat. 2010 Jan;119(2):367-7. doi:10.1007/s10549-009-0577-9. PubMed PMID: 19842034. See more on PubMed
    • Hao Y, Ma X, Luo Y, Hu X, Pan X, Xiao Y, Bao Y, Jia W. Associations of serumadipocyte fatty acid binding protein with body composition and fat distributionin nondiabetic Chinese women. J Clin Endocrinol Metab. 2015 May;100(5):2055-62.doi: 10.1210/jc.2014-4373. Epub 2015 Feb 26. PubMed PMID: 25719934. See more on PubMed
    • Horakova D, Pastucha D, Stejskal D, Kollarova H, Azeem K, Janout V. Adipocyte fatty acid binding protein and C-reactive protein levels as indicators of insulinresistance development. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011Dec;155(4):355-9. doi: 10.5507/bp.2011.042. PubMed PMID: 22336648. See more on PubMed
    • Horakova D, Stejskal D, Pastucha D, Muchova L, Janout V. Potential markers of insulin resistance in healthy vs obese and overweight subjects. Biomed Pap MedFac Univ Palacky Olomouc Czech Repub. 2010 Sep;154(3):245-9. PubMed PMID:21048811. See more on PubMed
    • Hsu BG, Chen YC, Lee RP, Lee CC, Lee CJ, Wang JH. Fasting serum level offatty-acid-binding protein 4 positively correlates with metabolic syndrome inpatients with coronary artery disease. Circ J. 2010 Feb;74(2):327-31. Epub 2009Dec 14. PubMed PMID: 20009357. See more on PubMed
    • Huang CL, Wu YW, Hsieh AR, Hung YH, Chen WJ, Yang WS. Serum adipocyte fattyacid-binding protein levels in patients with critical illness are associated withinsulin resistance and predict mortality. Crit Care. 2013 Feb 1;17(1):R22. doi:10.1186/cc12498. PubMed PMID: 23375099; PubMed Central PMCID: PMC4056759. See more on PubMed
    • Huang CL, Wu YW, Wu CC, Lin L, Wu YC, Hsu PY, Jong YS, Yang WS. Associationbetween serum adipocyte fatty-acid binding protein concentrations, leftventricular function and myocardial perfusion abnormalities in patients withcoronary artery disease. Cardiovasc Diabetol. 2013 Jul 17;12:105. doi:10.1186/1475-2840-12-105. PubMed PMID: 23866022; PubMed Central PMCID:PMC3733628. See more on PubMed
    • Hung CS, Wu YW, Huang JY, Hsu PY, Chen MF. Evaluation of circulatingadipokines and abdominal obesity as predictors of significant myocardial ischemiausing gated single-photon emission computed tomography. PLoS One. 2014 May19;9(5):e97710. doi: 10.1371/journal.pone.0097710. eCollection 2014. PubMed PMID:24842767; PubMed Central PMCID: PMC4026442. See more on PubMed
    • Ishimura S, Furuhashi M, Watanabe Y, Hoshina K, Fuseya T, Mita T, Okazaki Y,Koyama M, Tanaka M, Akasaka H, Ohnishi H, Yoshida H, Saitoh S, Miura T.Circulating levels of fatty acid-binding protein family and metabolic phenotypein the general population. PLoS One. 2013 Nov 20;8(11):e81318. doi:10.1371/journal.pone.0081318. eCollection 2013. PubMed PMID: 24278421; PubMedCentral PMCID: PMC3835575. See more on PubMed
    • Iso T, Sunaga H, Matsui H, Kasama S, Oshima N, Haruyama H, Furukawa N,Nakajima K, Machida T, Murakami M, Yokoyama T, Kurabayashi M. Serum levels offatty acid binding protein 4 and fat metabolic markers in relation tocatecholamines following exercise. Clin Biochem. 2017 Nov;50(16-17):896-902. doi:10.1016/j.clinbiochem.2017.05.021. Epub 2017 Jun 2. PubMed PMID: 28583436. See more on PubMed
    • Iwamoto M, Miyoshi T, Doi M, Takeda K, Kajiya M, Nosaka K, Nakayama R,Hirohata S, Usui S, Kusachi S, Sakane K, Nakamura K, Ito H. Elevated serumadipocyte fatty acid-binding protein concentrations are independently associated with renal dysfunction in patients with stable angina pectoris. CardiovascDiabetol. 2012 Mar 21;11:26. doi: 10.1186/1475-2840-11-26. PubMed PMID: 22433902;PubMed Central PMCID: PMC3353231. See more on PubMed
    • Jeon WS, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Lee WY. Association ofserum adipocyte-specific Fatty Acid binding protein with Fatty liver index as apredictive indicator of nonalcoholic Fatty liver disease. Endocrinol Metab(Seoul). 2013 Dec;28(4):283-7. doi: 10.3803/EnM.2013.28.4.283. Epub 2013 Dec 12. PubMed PMID: 24396693; PubMed Central PMCID: PMC3871043. See more on PubMed
    • Jin J, Peng DQ, Yuan SG, Zhao SP, Ning XH, Wang SH, Li SL. Serum adipocytefatty acid binding proteins and adiponectin in patients with coronary arterydisease: the significance of A-FABP/adiponectin ratio. Clin Chim Acta. 2010 Nov11;411(21-22):1761-5. doi: 10.1016/j.cca.2010.07.031. Epub 2010 Aug 2. PubMedPMID: 20688054. See more on PubMed
    • Kaess BM, Enserro DM, McManus DD, Xanthakis V, Chen MH, Sullivan LM, Ingram C,O'Donnell CJ, Keaney JF, Vasan RS, Glazer NL. Cardiometabolic correlates andheritability of fetuin-A, retinol-binding protein 4, and fatty-acid bindingprotein 4 in the Framingham Heart Study. J Clin Endocrinol Metab. 2012Oct;97(10):E1943-7. doi: 10.1210/jc.2012-1458. Epub 2012 Aug 1. PubMed PMID:22855337; PubMed Central PMCID: PMC3674297. See more on PubMed
    • Karakas SE, Almario RU, Kim K. Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers. Metabolism. 2009 Jul;58(7):1002-7. doi:10.1016/j.metabol.2009.02.024. PubMed PMID: 19394980; PubMed Central PMCID:PMC2720822. See more on PubMed
    • Karpisek M, Stejskal D, Kotolova H, Kollar P, Janoutova G, Ochmanova R, Cizek L, Horakova D, Yahia RB, Lichnovska R, Janout V. Treatment with atorvastatinreduces serum adipocyte-fatty acid binding protein value in patients withhyperlipidaemia. Eur J Clin Invest. 2007 Aug;37(8):637-42. PubMed PMID: 17635574. See more on PubMed
    • Kim TN, Won JC, Kim YJ, Lee EJ, Kim MK, Park MS, Lee SK, Kim JM, Ko KS, RheeBD. Serum adipocyte fatty acid-binding protein levels are independentlyassociated with sarcopenic obesity. Diabetes Res Clin Pract. 2013Aug;101(2):210-7. doi: 10.1016/j.diabres.2013.05.014. Epub 2013 Jul 4. PubMedPMID: 23830287. See more on PubMed
    • Kim YC, Cho YK, Lee WY, Kim HJ, Park JH, Park DI, Sohn CI, Jeon WK, Kim BI,Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Kim SW, Ryu SH. Serumadipocyte-specific fatty acid-binding protein is associated with nonalcoholicfatty liver disease in apparently healthy subjects. J Nutr Biochem. 2011Mar;22(3):289-92. doi: 10.1016/j.jnutbio.2010.02.007. Epub 2010 Jun 25. PubMedPMID: 20579864. See more on PubMed
    • Koh JH, Shin YG, Nam SM, Lee MY, Chung CH, Shin JY. Serum adipocyte fattyacid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Diabetes Care. 2009 Jan;32(1):147-52. doi:10.2337/dc08-1379. Epub 2008 Oct 3. PubMed PMID: 18835952; PubMed Central PMCID: PMC2606851. See more on PubMed
    • Kotulak T, Drapalova J, Lips M, Lacinova Z, Kramar P, Riha H, Netuka I, MalyJ, Blaha J, Lindner J, Svacina S, Mraz M, Haluzik M. Cardiac surgery increasesserum concentrations of adipocyte fatty acid-binding protein and its mRNAexpression in circulating monocytes but not in adipose tissue. Physiol Res.2014;63(1):83-94. Epub 2013 Nov 1. PubMed PMID: 24182337. See more on PubMed
    • Kralisch S, Ebert T, Lossner U, Jessnitzer B, Stumvoll M, Fasshauer M.Adipocyte fatty acid-binding protein is released from adipocytes by anon-conventional mechanism. Int J Obes (Lond). 2014 Sep;38(9):1251-4. doi:10.1038/ijo.2013.232. Epub 2013 Dec 13. PubMed PMID: 24445660. See more on PubMed
    • Kralisch S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, LössnerU, Blüher M, Stumvoll M, Fasshauer M. Serum levels of adipocyte fatty acidbinding protein are increased in gestational diabetes mellitus. Eur J Endocrinol.2009 Jan;160(1):33-8. doi: 10.1530/EJE-08-0540. Epub 2008 Oct 10. PubMed PMID:18849305. See more on PubMed
    • Lam DC, Xu A, Lam KS, Lam B, Lam JC, Lui MM, Ip MS. Serum adipocyte-fatty acidbinding protein level is elevated in severe OSA and correlates with insulinresistance. Eur Respir J. 2009 Feb;33(2):346-51. doi: 10.1183/09031936.50075408. PubMed PMID: 19181913. See more on PubMed
    • Lamounier-Zepter V, Look C, Alvarez J, Christ T, Ravens U, Schunck WH,Ehrhart-Bornstein M, Bornstein SR, Morano I. Adipocyte fatty acid-binding proteinsuppresses cardiomyocyte contraction: a new link between obesity and heartdisease. Circ Res. 2009 Aug 14;105(4):326-34. doi: 10.1161/CIRCRESAHA.109.200501.Epub 2009 Jul 16. PubMed PMID: 19608978. See more on PubMed
    • Lázaro I, Díaz M, Cabré A, Masana L, Ibáñez L. Fatty acid-binding protein-4plasma levels are associated to metabolic abnormalities and response to therapyin girls and young women with androgen excess. Gynecol Endocrinol. 2011Nov;27(11):935-9. doi: 10.3109/09513590.2011.569608. Epub 2011 May 24. PubMedPMID: 21605000. See more on PubMed
    • Lázaro I, Ferré R, Plana N, Aragonès G, Girona J, Merino J, Heras M, Cabré A, Masana L. Lifestyle changes lower FABP4 plasma concentration in patients withcardiovascular risk. Rev Esp Cardiol (Engl Ed). 2012 Feb;65(2):152-7. doi:10.1016/j.recesp.2011.09.016. Epub 2011 Dec 5. English, Spanish. PubMed PMID:22153726. See more on PubMed
    • Liu Y, Wang D, Li D, Sun R, Xia M. Associations of retinol-binding protein 4with oxidative stress, inflammatory markers, and metabolic syndrome in amiddle-aged and elderly Chinese population. Diabetol Metab Syndr. 2014 Feb24;6(1):25. doi: 10.1186/1758-5996-6-25. PubMed PMID: 24559154; PubMed CentralPMCID: PMC3938900. See more on PubMed
    • Li B, Yang H, Zhang W, Shi Y, Qin S, Wei Y, He Y, Yang W, Jiang S, Jin H.Fatty acid-binding protein 4 predicts gestational hypertension and preeclampsiain women with gestational diabetes mellitus. PLoS One. 2018 Feb 2;13(2):e0192347.doi: 10.1371/journal.pone.0192347. eCollection 2018. PubMed PMID: 29394285;PubMed Central PMCID: PMC5796716. See more on PubMed
    • Lu L, Wang YN, Sun WH, Liu ZH, Zhang Q, Pu LJ, Yang K, Wang LJ, Zhu ZB, MengH, Yang P, Du R, Chen QJ, Wang LS, Yu H, Shen WF. Two-dimensional fluorescencein-gel electrophoresis of coronary restenosis tissues in minipigs: increasedadipocyte fatty acid binding protein induces reactive oxygen species-mediatedgrowth and migration in smooth muscle cells. Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):572-80. doi: 10.1161/ATVBAHA.112.301016. Epub 2013 Jan 31. PubMed PMID:23372061. See more on PubMed
    • Lui MM, Lam JC, Mak HK, Xu A, Ooi C, Lam DC, Mak JC, Khong PL, Ip MS.C-reactive protein is associated with obstructive sleep apnea independent ofvisceral obesity. Chest. 2009 Apr;135(4):950-956. doi: 10.1378/chest.08-1798.Epub 2009 Feb 18. Erratum in: Chest. 2009 May;135(5):1406. PubMed PMID: 19225064. See more on PubMed
    • Messina S, Vargas-Lowy D, Musallam A, Healy BC, Kivisakk P, Gandhi R, Bove R, Gholipour T, Khoury S, Weiner HL, Chitnis T. Increased leptin and A-FABP levelsin relapsing and progressive forms of MS. BMC Neurol. 2013 Nov 11;13:172. doi:10.1186/1471-2377-13-172. PubMed PMID: 24215402; PubMed Central PMCID:PMC3829106. See more on PubMed
    • Milner KL, van der Poorten D, Xu A, Bugianesi E, Kench JG, Lam KS, ChisholmDJ, George J. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology. 2009Jun;49(6):1926-34. doi: 10.1002/hep.22896. PubMed PMID: 19475694. See more on PubMed
    • Miyoshi T, Doi M, Hirohata S, Kamikawa S, Usui S, Ogawa H, Sakane K, Izumi R, Ninomiya Y, Kusachi S. Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients. Heart Vessels. 2011Jul;26(4):408-13. doi: 10.1007/s00380-010-0060-x. Epub 2010 Nov 10. PubMed PMID: 21063874. See more on PubMed
    • Miyoshi T, Onoue G, Hirohata A, Hirohata S, Usui S, Hina K, Kawamura H, Doi M,Kusano KF, Kusachi S, Ninomiya Y. Serum adipocyte fatty acid-binding protein isindependently associated with coronary atherosclerotic burden measured byintravascular ultrasound. Atherosclerosis. 2010 Jul;211(1):164-9. doi:10.1016/j.atherosclerosis.2010.01.032. Epub 2010 Feb 4. PubMed PMID: 20193950. See more on PubMed
    • Möhlig M, Weickert MO, Ghadamgadai E, Machlitt A, Pfüller B, Arafat AM,Pfeiffer AF, Schöfl C. Adipocyte fatty acid-binding protein is associated withmarkers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Eur J Endocrinol. 2007Aug;157(2):195-200. PubMed PMID: 17656598. See more on PubMed
    • Morieri ML, Guardigni V, Sanz JM, Dalla Nora E, Soavi C, Zuliani G, SighinolfiL, Passaro A. Adipokines levels in HIV infected patients: lipocalin-2 and fattyacid binding protein-4 as possible markers of HIV and antiretroviraltherapy-related adipose tissue inflammation. BMC Infect Dis. 2018 Jan 5;18(1):10.doi: 10.1186/s12879-017-2925-4. PubMed PMID: 29304747; PubMed Central PMCID:PMC5756414. See more on PubMed
    • Nagaev I, Bokarewa M, Tarkowski A, Smith U. Human resistin is a systemicimmune-derived proinflammatory cytokine targeting both leukocytes and adipocytes.PLoS One. 2006 Dec 20;1:e31. PubMed PMID: 17183659; PubMed Central PMCID:PMC1762367. See more on PubMed
    • Ni X, Gu Y, Yu H, Wang S, Chen Y, Wang X, Yuan X, Jia W. Serum Adipocyte FattyAcid-Binding Protein 4 Levels Are Independently Associated with RadioisotopeGlomerular Filtration Rate in Type 2 Diabetic Patients with Early DiabeticNephropathy. Biomed Res Int. 2018 May 27;2018:4578140. doi: 10.1155/2018/4578140.eCollection 2018. PubMed PMID: 29992142; PubMed Central PMCID: PMC5994326. See more on PubMed
    • Novotny D, Vaverkova H, Karasek D, Lukes J, Slavik L, Malina P, Orsag J.Evaluation of total adiponectin, adipocyte fatty acid binding protein andfibroblast growth factor 21 levels in individuals with metabolic syndrome.Physiol Res. 2014;63(2):219-28. Epub 2014 Jan 8. PubMed PMID: 24397811. See more on PubMed
    • Ortega-Senovilla H, Schaefer-Graf U, Meitzner K, Abou-Dakn M, Graf K,Kintscher U, Herrera E. Gestational diabetes mellitus causes changes in theconcentrations of adipocyte fatty acid-binding protein and other adipocytokinesin cord blood. Diabetes Care. 2011 Sep;34(9):2061-6. doi: 10.2337/dc11-0715. Epub2011 Jul 20. PubMed PMID: 21775757; PubMed Central PMCID: PMC3161255. See more on PubMed
    • Pala L, Monami M, Ciani S, Dicembrini I, Pasqua A, Pezzatini A, Francesconi P,Cresci B, Mannucci E, Rotella CM. Adipokines as possible new predictors ofcardiovascular diseases: a case control study. J Nutr Metab. 2012;2012:253428.doi: 10.1155/2012/253428. Epub 2011 Aug 22. PubMed PMID: 21869928; PubMed CentralPMCID: PMC3160046. See more on PubMed
    • Park SE, Rhee EJ, Lee WY, Kim WJ, Yoo SH, Bae JC, Choi ES, Park CY, Oh KW,Park SW, Kim SW. The role of serum adipocyte fatty acid-binding protein on thedevelopment of metabolic syndrome is independent of pro-inflammatory cytokines.Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):525-32. doi:10.1016/j.numecd.2010.09.008. Epub 2010 Dec 24. PubMed PMID: 21186114. See more on PubMed
    • Queipo-Ortuño MI, Escoté X, Ceperuelo-Mallafré V, Garrido-Sanchez L, MirandaM, Clemente-Postigo M, Pérez-Pérez R, Peral B, Cardona F, Fernández-Real JM,Tinahones FJ, Vendrell J. FABP4 dynamics in obesity: discrepancies in adiposetissue and liver expression regarding circulating plasma levels. PLoS One.2012;7(11):e48605. doi: 10.1371/journal.pone.0048605. Epub 2012 Nov 5. PubMedPMID: 23139800; PubMed Central PMCID: PMC3489666. See more on PubMed
    • Reinehr T, Stoffel-Wagner B, Roth CL. Adipocyte fatty acid-binding protein in obese children before and after weight loss. Metabolism. 2007 Dec;56(12):1735-41.PubMed PMID: 17998029. See more on PubMed
    • Rhee EJ, Lee WY, Park CY, Oh KW, Kim BJ, Sung KC, Kim BS. The association ofserum adipocyte fatty acid-binding protein with coronary artery disease in Koreanadults. Eur J Endocrinol. 2009 Feb;160(2):165-72. doi: 10.1530/EJE-08-0665. Epub 2008 Nov 11. PubMed PMID: 19001529. See more on PubMed
    • Schmilovitz-Weiss H, Laish I, Levi Z, Monsselise Y, Harif Y, Braun M, Boaz M, Ben-Ari Z. Serum adipocyte fatty acid binding protein in liver transplantrecipients and the metabolic syndrome. Ann Hepatol. 2012 May-Jun;11(3):343-9.PubMed PMID: 22481453. See more on PubMed
    • Scifres CM, Catov JM, Simhan H. Maternal serum fatty acid binding protein 4(FABP4) and the development of preeclampsia. J Clin Endocrinol Metab. 2012Mar;97(3):E349-56. doi: 10.1210/jc.2011-2276. Epub 2011 Dec 21. PubMed PMID:22188744. See more on PubMed
    • Shangguan X, Liu F, Wang H, He J, Dong M. Alterations in serum adipocyte fattyacid binding protein and retinol binding protein-4 in normal pregnancy andpreeclampsia. Clin Chim Acta. 2009 Sep;407(1-2):58-61. doi:10.1016/j.cca.2009.06.031. Epub 2009 Jun 29. PubMed PMID: 19573524. See more on PubMed
    • Shen J, Chan HL, Wong GL, Choi PC, Chan AW, Chan HY, Chim AM, Yeung DK, ChanFK, Woo J, Yu J, Chu WC, Wong VW. Non-invasive diagnosis of non-alcoholicsteatohepatitis by combined serum biomarkers. J Hepatol. 2012 Jun;56(6):1363-70. doi: 10.1016/j.jhep.2011.12.025. Epub 2012 Feb 4. PubMed PMID: 22314419. See more on PubMed
    • Siahanidou T, Margeli A, Davradou M, Apostolakou F, Papassotiriou I, Roma E,Mandyla H, Chrousos G. Circulating adipocyte fatty acid binding protein levels inhealthy preterm infants: Positive correlation with weight gain andtotal-cholesterol levels. Early Hum Dev. 2010 Apr;86(4):197-201. doi:10.1016/j.earlhumdev.2010.02.008. Epub 2010 Mar 15. PubMed PMID: 20231079. See more on PubMed
    • Simón I, Escoté X, Vilarrasa N, Gómez J, Fernández-Real JM, Megía A, GutiérrezC, Gallart L, Masdevall C, Vendrell J. Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women. Obesity (SilverSpring). 2009 Jun;17(6):1124-8. doi: 10.1038/oby.2008.665. Epub 2009 Feb 5.PubMed PMID: 19197257. See more on PubMed
    • Sommer G, Ziegelmeier M, Bachmann A, Kralisch S, Lossner U, Kratzsch J, BlüherM, Stumvoll M, Fasshauer M. Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin Endocrinol (Oxf). 2008 Dec;69(6):901-5. doi: 10.1111/j.1365-2265.2008.03277.x. Epub 2008 Apr 16. PubMed PMID: 18419784. See more on PubMed
    • Sovova E, Hobzova M, Stejskal D, Sova M, Kolek V, Zapletalova J. Treatment of obstructive sleep apnea with continuous positive airway pressure decreasesadipocyte fatty acid-binding protein levels. Biomed Pap Med Fac Univ PalackyOlomouc Czech Repub. 2012 Mar;156(1):58-62. doi: 10.5507/bp.2011.066. PubMedPMID: 22580862. See more on PubMed
    • Sovova E, Sova M, Zapletalova J, Stejskal D, Sovova M, Kaletova M, SvobodovaG, Kuca I, Janak M, Kaminek M. Possitive correlation between adipocyte fattyacid-binding protein and epicardial fat in patients with a family history ofcardiovascular disesase. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.2017 Jun;161(2):174-178. doi: 10.5507/bp.2017.018. Epub 2017 May 16. PubMed PMID:28539672. See more on PubMed
    • Spartano NL, Stevenson MD, Xanthakis V, Larson MG, Andersson C, Murabito JM,Vasan RS. Associations of objective physical activity with insulin sensitivityand circulating adipokine profile: the Framingham Heart Study. Clin Obes. 2017Apr;7(2):59-69. doi: 10.1111/cob.12177. Epub 2017 Jan 23. PubMed PMID: 28112860; PubMed Central PMCID: PMC5339058. See more on PubMed
    • Stefanska A, Ponikowska I, Sypniewska G. A-FABP concentration is more stronglyassociated with cardiometabolic risk factors and the occurrence of metabolicsyndrome in premenopausal than in postmenopausal middle-aged women. Biomed ResInt. 2014;2014:645762. doi: 10.1155/2014/645762. Epub 2014 May 29. PubMed PMID:24971341; PubMed Central PMCID: PMC4058146. See more on PubMed
    • Stefanska A, Sypniewska G, Blaszkiewicz B, Ponikowska I, Cwiklinska-Jurkowska M. Comparison between C-reactive protein and adipocyte fatty acid-binding proteinas a component of metabolic syndrome in middle-aged women. Clin Biochem. 2011Mar;44(4):304-6. doi: 10.1016/j.clinbiochem.2010.12.002. Epub 2010 Dec 13. PubMedPMID: 21159316. See more on PubMed
    • Stejskal D, Karpisek M. Adipocyte fatty acid binding protein in a Caucasianpopulation: a new marker of metabolic syndrome? Eur J Clin Invest. 2006Sep;36(9):621-5. PubMed PMID: 16919044. See more on PubMed
    • Stejskal D, Karpisek M, Bronsky J. Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss. J Clin Lab Anal. 2008;22(5):380-2. doi: 10.1002/jcla.20270. PubMed PMID: 18803274. See more on PubMed
    • Terra X, Quintero Y, Auguet T, Porras JA, Hernández M, Sabench F, Aguilar C,Luna AM, Del Castillo D, Richart C. FABP 4 is associated with inflammatorymarkers and metabolic syndrome in morbidly obese women. Eur J Endocrinol. 2011Apr;164(4):539-47. doi: 10.1530/EJE-10-1195. Epub 2011 Jan 21. PubMed PMID:21257725. See more on PubMed
    • Teunissen CE, Elias N, Koel-Simmelink MJ, Durieux-Lu S, Malekzadeh A, Pham TV,Piersma SR, Beccari T, Meeter LH, Dopper EG, van Swieten JC, Jimenez CR,Pijnenburg YA. Novel diagnostic cerebrospinal fluid biomarkers for pathologicsubtypes of frontotemporal dementia identified by proteomics. Alzheimers Dement(Amst). 2016 Jan 19;2:86-94. doi: 10.1016/j.dadm.2015.12.004. eCollection 2016.PubMed PMID: 27239539; PubMed Central PMCID: PMC4879654. See more on PubMed
    • Tönjes A, Kralisch S, Lössner U, Kovacs P, Blüher M, Stumvoll M, Fasshauer M. Metabolic and genetic predictors of circulating adipocyte fatty acid-bindingprotein. Int J Obes (Lond). 2012 Jun;36(6):766-73. doi: 10.1038/ijo.2011.162.Epub 2011 Aug 23. PubMed PMID: 21863005. See more on PubMed
    • Toruner F, Altinova AE, Akturk M, Kaya M, Arslan E, Bukan N, Kan E, Yetkin I, Arslan M. The relationship between adipocyte fatty acid binding protein-4,retinol binding protein-4 levels and early diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract. 2011 Feb;91(2):203-7. doi:10.1016/j.diabres.2010.11.011. Epub 2010 Dec 19. PubMed PMID: 21176857. See more on PubMed
    • Tsai JP, Liou HH, Liu HM, Lee CJ, Lee RP, Hsu BG. Fasting serum fattyacid-binding protein 4 level positively correlates with metabolic syndrome inhemodialysis patients. Arch Med Res. 2010 Oct;41(7):536-40. doi:10.1016/j.arcmed.2010.09.007. PubMed PMID: 21167393. See more on PubMed
    • Tso AW, Xu A, Sham PC, Wat NM, Wang Y, Fong CH, Cheung BM, Janus ED, Lam KS.Serum adipocyte fatty acid binding protein as a new biomarker predicting thedevelopment of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care. 2007 Oct;30(10):2667-72. Epub 2007 Jul 9. PubMed PMID: 17620449. See more on PubMed
    • Tuuri AL, Jauhiainen MS, Tikkanen MJ, Kaaja RJ. Systolic blood pressure andfatty acid-binding protein 4 predict pregnancy-induced hypertension in overweightnulliparous women. Placenta. 2014 Oct;35(10):797-801. doi:10.1016/j.placenta.2014.07.016. Epub 2014 Aug 5. PubMed PMID: 25130095. See more on PubMed
    • von Eynatten M, Breitling LP, Roos M, Baumann M, Rothenbacher D, Brenner H.Circulating adipocyte fatty acid-binding protein levels and cardiovascularmorbidity and mortality in patients with coronary heart disease: a 10-yearprospective study. Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2327-35. doi:10.1161/ATVBAHA.112.248609. Epub 2012 Jun 7. PubMed PMID: 22679309. See more on PubMed
    • von Jeinsen B, Short MI, Xanthakis V, Carneiro H, Cheng S, Mitchell GF, Vasan RS. Association of Circulating Adipokines With Echocardiographic Measures ofCardiac Structure and Function in a Community-Based Cohort. J Am Heart Assoc.2018 Jun 21;7(13). pii: e008997. doi: 10.1161/JAHA.118.008997. PubMed PMID:29929991; PubMed Central PMCID: PMC6064918. See more on PubMed
    • Woo YC, Tso AW, Xu A, Law LS, Fong CH, Lam TH, Lo SV, Wat NM, Cheung BM, LamKS. Combined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction. PLoSOne. 2012;7(5):e36868. doi: 10.1371/journal.pone.0036868. Epub 2012 May 16.PubMed PMID: 22615828; PubMed Central PMCID: PMC3353952. See more on PubMed
    • Wu LE, Samocha-Bonet D, Whitworth PT, Fazakerley DJ, Turner N, Biden TJ, JamesDE, Cantley J. Identification of fatty acid binding protein 4 as an adipokinethat regulates insulin secretion during obesity. Mol Metab. 2014 Mar14;3(4):465-73. doi: 10.1016/j.molmet.2014.02.005. eCollection 2014 Jul. PubMedPMID: 24944906; PubMed Central PMCID: PMC4060222. See more on PubMed
    • Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, Yeung DC, Janus ED, Sham PC,Lam KS. Circulating adipocyte-fatty acid binding protein levels predict thedevelopment of the metabolic syndrome: a 5-year prospective study. Circulation.2007 Mar 27;115(12):1537-43. PubMed PMID: 17389279. See more on PubMed
    • Xu A, Vanhoutte PM. Adiponectin and adipocyte fatty acid binding protein inthe pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol. 2012Mar 15;302(6):H1231-40. doi: 10.1152/ajpheart.00765.2011. Epub 2011 Dec 30.Review. PubMed PMID: 22210749. See more on PubMed
    • Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NM, Wong WK, Lam KS.Adipocyte fatty acid-binding protein is a plasma biomarker closely associatedwith obesity and metabolic syndrome. Clin Chem. 2006 Mar;52(3):405-13. Epub 2006 Jan 19. PubMed PMID: 16423904. See more on PubMed
    • Yamada M, Mochizuki K, Honma K, Miyauchi R, Kasezawa N, Tohyama K, Goda T.Serum Fatty Acid Binding Protein 4 Concentrations Are Positively andIndependently Associated with Blood Pressure and Abdominal Fat among Parametersin Health Check-Ups in Ordinary Middle-Aged Japanese Males. J Nutr Sci Vitaminol (Tokyo). 2015;61(4):291-8. doi: 10.3177/jnsv.61.291. PubMed PMID: 26440635. See more on PubMed
    • Yeung DC, Lam KS, Wang Y, Tso AW, Xu A. Serum zinc-alpha2-glycoproteincorrelates with adiposity, triglycerides, and the key components of the metabolicsyndrome in Chinese subjects. J Clin Endocrinol Metab. 2009 Jul;94(7):2531-6.doi: 10.1210/jc.2009-0058. Epub 2009 Apr 7. PubMed PMID: 19351730. See more on PubMed
    • Yeung DC, Wang Y, Xu A, Cheung SC, Wat NM, Fong DY, Fong CH, Chau MT, Sham PC,Lam KS. Epidermal fatty-acid-binding protein: a new circulating biomarkerassociated with cardio-metabolic risk factors and carotid atherosclerosis. EurHeart J. 2008 Sep;29(17):2156-63. doi: 10.1093/eurheartj/ehn295. Epub 2008 Jul 4.PubMed PMID: 18603624. See more on PubMed
    • Yeung DC, Xu A, Cheung CW, Wat NM, Yau MH, Fong CH, Chau MT, Lam KS. Serumadipocyte fatty acid-binding protein levels were independently associated withcarotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1796-802. Epub 2007 May 17. PubMed PMID: 17510463. See more on PubMed
    • Yeung DC, Xu A, Tso AW, Chow WS, Wat NM, Fong CH, Tam S, Sham PC, Lam KS.Circulating levels of adipocyte and epidermal fatty acid-binding proteins inrelation to nephropathy staging and macrovascular complications in type 2diabetic patients. Diabetes Care. 2009 Jan;32(1):132-4. doi: 10.2337/dc08-1333.Epub 2008 Oct 17. PubMed PMID: 18931100; PubMed Central PMCID: PMC2606847. See more on PubMed
    • Yoo HJ, Kim S, Park MS, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Baik SH,Choi DS, Choi KM. Serum adipocyte fatty acid-binding protein is associatedindependently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography. J Clin Endocrinol Metab. 2011 Mar;96(3):E488-92.doi: 10.1210/jc.2010-1473. Epub 2010 Dec 15. PubMed PMID: 21159847. See more on PubMed
    • Yun KE, Kim SM, Choi KM, Park HS. Association between adipocyte fattyacid-binding protein levels and childhood obesity in Korean children. Metabolism.2009 Jun;58(6):798-802. doi: 10.1016/j.metabol.2009.01.017. PubMed PMID:19368945. See more on PubMed
    • Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RL, Chow WS,Tso AW, Lam KS, Xu A. Serum FGF21 levels are increased in obesity and areindependently associated with the metabolic syndrome in humans. Diabetes. 2008May;57(5):1246-53. doi: 10.2337/db07-1476. Epub 2008 Feb 5. Erratum in: Diabetes.2019 Jan;68(1):235. PubMed PMID: 18252893. See more on PubMed
    • Zhou M, Bao Y, Li H, Pan Y, Shu L, Xia Z, Wu D, Lam KS, Vanhoutte PM, Xu A,Jia W, Hoo RL. Deficiency of adipocyte fatty-acid-binding protein alleviatesmyocardial ischaemia/reperfusion injury and diabetes-induced cardiac dysfunction.Clin Sci (Lond). 2015 Oct;129(7):547-59. doi: 10.1042/CS20150073. Epub 2015 Jun11. PubMed PMID: 26186740. See more on PubMed
    • Takagi W, Miyoshi T, Doi M, Okawa K, Nosaka K, Nishibe T, Matsuo N, HirohataS, Ito H. Circulating adipocyte fatty acid-binding protein is a predictor ofcardiovascular events in patients with stable angina undergoing percutaneouscoronary intervention. BMC Cardiovasc Disord. 2017 Oct 10;17(1):258. doi:10.1186/s12872-017-0691-2. PubMed PMID: 29017449; PubMed Central PMCID:PMC5635577. See more on PubMed
    • Zachariah JP, Quiroz R, Nelson KP, Teng Z, Keaney JF Jr, Sullivan LM, VasanRS. Prospective Relation of Circulating Adipokines to Incident MetabolicSyndrome: The Framingham Heart Study. J Am Heart Assoc. 2017 Jul 16;6(7). pii:e004974. doi: 10.1161/JAHA.116.004974. PubMed PMID: 28713076; PubMed CentralPMCID: PMC5586264. See more on PubMed
    • Manco M, Nobili V, Alisi A, Panera N, Handberg A. Arterial Stiffness,Thickness and Association to Suitable Novel Markers of Risk at the Origin ofCardiovascular Disease in Obese Children. Int J Med Sci. 2017 Jul12;14(8):711-720. doi: 10.7150/ijms.20126. eCollection 2017. PubMed PMID:28824305; PubMed Central PMCID: PMC5562124. See more on PubMed
    • Guaita-Esteruelas S, Saavedra-García P, Bosquet A, Borràs J, Girona J,Amiliano K, Rodríguez-Balada M, Heras M, Masana L, Gumà J. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast CancerPatients. Oncologist. 2017 Nov;22(11):1309-1315. doi:10.1634/theoncologist.2016-0483. Epub 2017 Jul 12. PubMed PMID: 28701570; PubMed Central PMCID: PMC5679823. See more on PubMed
    • Nakamura R, Okura T, Fujioka Y, Sumi K, Matsuzawa K, Izawa S, Ueta E, Kato M, Taniguchi SI, Yamamoto K. Correction: Serum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, Aclinical study. PLoS One. 2019 Jan 14;14(1):e0210932. doi:10.1371/journal.pone.0210932. eCollection 2019. PubMed PMID: 30640959; PubMedCentral PMCID: PMC6331087. See more on PubMed
    • Eichelmann F, Weikert C, di Giuseppe R, Biemann R, Isermann B, Schulze MB,Boeing H, Aleksandrova K. Methodological utility of chemerin as a novel biomarkerof immunity and metabolism. Endocr Connect. 2017 Jul;6(5):340-347. doi:10.1530/EC-17-0098. Epub 2017 Jun 7. PubMed PMID: 28592510; PubMed Central PMCID:PMC5510453. See more on PubMed
  • References to Adipocyte FABP (FABP4) Mouse ELISA

    • Vila IK, Badin PM, Marques MA, Monbrun L, Lefort C, Mir L, Louche K, Bourlier V, Roussel B, Gui P, Grober J, Štich V, Rossmeislová L, Zakaroff-Girard A,Bouloumié A, Viguerie N, Moro C, Tavernier G, Langin D. Immune cell Toll-likereceptor 4 mediates the development of obesity- and endotoxemia-associatedadipose tissue fibrosis. Cell Rep. 2014 May 22;7(4):1116-29. doi:10.1016/j.celrep.2014.03.062. Epub 2014 May 1. PubMed PMID: 24794440. See more on PubMed
    • Shu L, Hoo RL, Wu X, Pan Y, Lee IP, Cheong LY, Bornstein SR, Rong X, Guo J, XuA. A-FABP mediates adaptive thermogenesis by promoting intracellular activationof thyroid hormones in brown adipocytes. Nat Commun. 2017 Jan 27;8:14147. doi:10.1038/ncomms14147. PubMed PMID: 28128199; PubMed Central PMCID: PMC5290165. See more on PubMed
    • Shrestha S, Sunaga H, Hanaoka H, Yamaguchi A, Kuwahara S, Umbarawan Y,Nakajima K, Machida T, Murakami M, Saito A, Tsushima Y, Kurabayashi M, Iso T.Circulating FABP4 is eliminated by the kidney via glomerular filtration followed by megalin-mediated reabsorption. Sci Rep. 2018 Nov 6;8(1):16451. doi:10.1038/s41598-018-34902-w. PubMed PMID: 30401801; PubMed Central PMCID:PMC6219568. See more on PubMed
    • Villeneuve J, Bassaganyas L, Lepreux S, Chiritoiu M, Costet P, Ripoche J,Malhotra V, Schekman R. Unconventional secretion of FABP4 by endosomes andsecretory lysosomes. J Cell Biol. 2018 Feb 5;217(2):649-665. doi:10.1083/jcb.201705047. Epub 2017 Dec 6. PubMed PMID: 29212659; PubMed CentralPMCID: PMC5800802. See more on PubMed
    • Yang R, Castriota G, Chen Y, Cleary MA, Ellsworth K, Shin MK, Tran JL, VogtTF, Wu M, Xu S, Yang X, Zhang BB, Berger JP, Qureshi SA. RNAi-mediated germlineknockdown of FABP4 increases body weight but does not improve the derangednutrient metabolism of diet-induced obese mice. Int J Obes (Lond). 2011Feb;35(2):217-25. doi: 10.1038/ijo.2010.128. Epub 2010 Jul 6. PubMed PMID:20603627; PubMed Central PMCID: PMC3056343. See more on PubMed
  • References to Adipocyte Fatty Acid Binding Protein Human E. coli Tag free

    • Ayyar BV, Hearty S, O'Kennedy R. Highly sensitive recombinant antibodiescapable of reliably differentiating heart-type fatty acid binding protein fromnoncardiac isoforms. Anal Biochem. 2010 Dec 15;407(2):165-71. doi:10.1016/j.ab.2010.07.033. Epub 2010 Aug 7. PubMed PMID: 20696127. See more on PubMed
    • Nagata S, Fujii K, Matsushima T, Fukui M, Sadoshima S, Kuwabara Y, Abe H.Evaluation of EC-IC bypass for patients with atherosclerotic occlusivecerebrovascular disease: clinical and positron emission tomographic studies.Neurol Res. 1991 Dec;13(4):209-16. PubMed PMID: 1687329. See more on PubMed
  • References to Adipocyte Fatty Acid Binding Protein Human, Goat Polyclonal Antibody

    • Aragonès G, Saavedra P, Heras M, Cabré A, Girona J, Masana L. Fattyacid-binding protein 4 impairs the insulin-dependent nitric oxide pathway invascular endothelial cells. Cardiovasc Diabetol. 2012 Jun 18;11:72. doi:10.1186/1475-2840-11-72. PubMed PMID: 22709426; PubMed Central PMCID: PMC3503556. See more on PubMed
  • References to Adipocyte Fatty Acid Binding Protein Human, Rabbit Polyclonal Antibody

    • Andrés Cerezo L, Kuklová M, Hulejová H, Vernerová Z, Pešáková V, Pecha O,Veigl D, Haluzík M, Pavelka K, Vencovský J, Senolt L. The level of fattyacid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritisand correlates with serum cholesterol levels. Cytokine. 2013 Oct;64(1):441-7.doi: 10.1016/j.cyto.2013.05.001. Epub 2013 May 25. PubMed PMID: 23714112. See more on PubMed
    • Gazitt Y, Ohad I, Loyter A. Changes in phosoholipid susceptibility towardphospholipases induced by ATP depletion in avian and amphibian erythrocytemembranes. Biochim Biophys Acta. 1975 Feb 28;382(1):65-72. PubMed PMID: 164239. See more on PubMed